Pendo.io, Inc. – Trademark Portfolio
Entity Type: 03
Pendo.io, Inc. holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 9 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 3 Nice Classification classes. Currently, 4 trademarks are registered and 6 are pending. Notable registered marks include PENDO, INDUSTRY, PENDOMONIUM, and PRODUCTCRAFT. The owner is based in Raleigh, NC.
301 Hillsborough Street, Suite 1900
Raleigh, NC 27603
Showing of trademarks Trademarks
Trademark Classifications
Pendo.io, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Pendo.io, Inc. have?
Pendo.io, Inc. has 12 U.S. trademarks filed with the USPTO. Of these, 4 registered, 6 pending, 1 abandoned, 1 cancelled.
What trademark classes does Pendo.io, Inc. file in?
Pendo.io, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 41 (Education & Entertainment), Class 35 (Advertising & Business). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Pendo.io, Inc.'s most well-known trademarks?
Pendo.io, Inc.'s registered trademark portfolio includes well-known marks such as PENDO, INDUSTRY, PENDOMONIUM, and PRODUCTCRAFT. These are among 4 currently registered trademarks in the portfolio.
What is Pendo.io, Inc.'s trademark registration success rate?
Pendo.io, Inc. has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 6 applications are pending review.